Ml. Casey et Pc. Macdonald, KERATINOCYTE GROWTH-FACTOR EXPRESSION IN THE MESENCHYMAL CELLS OF HUMAN AMNION, The Journal of clinical endocrinology and metabolism, 82(10), 1997, pp. 3319-3323
Amnion epithelial and mesenchymal cells were separated by differential
protease treatment, and the separated cells were maintained in monola
yer culture. Keratinocyte growth factor (KGF) mes senger RNA (mRNA) wa
s readily detected by Northern analysis of amnion mesenchymal cell tot
al RNA (10 mu g) but not in amnion epithelial cells. Treatment of the
amnion mesenchymal cells in serum-free medium with tetradecanoyl phorb
ol acetate (1 nM) caused an increase in the level of KGF mRNA. Forskol
in treatment also caused an increase in KGF mRNA but not to the levels
attained with tetradecanoyl phorbol acetate treatment. Dexamethasone
(1 nM) treatment of these cells effected a reduction in the level of K
GF mRNA. Prolonged maintenance of mesenchymal cells in serum-free medi
um also was associated with an increase in the level of KGF mRNA. Trea
tment with a variety of other agents, viz., interleukin (IL)-1, IL-6 p
lus or minus IL-6 soluble receptor, IL-11, oncostatin M, epidermal gro
wth factor (EGF), and transforming growth factor-beta did not modify t
he level of KGF mRNA. Treatment of amnion epithelial cells with KGF ca
used an increase in the rate of [H-3]thymidine incorporation, but the
rate of cell replication induced by KGF was less than that induced by
treatment with EGF. Transforming growth factor-beta treatment inhibite
d basal and EGF-and KGF- stimulated amnion epithelial cell replication
. The findings of this study are indicative that KGF is expressed in h
uman amnion mesenchymal cells, and that KGF may act on the epithelial
cells of this tissue.